Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study

Author:

Cho Kyu Yong12ORCID,Nomoto Hiroshi1ORCID,Nakamura Akinobu1ORCID,Kawata Shinichiro1,Sugawara Hajime3,Takeuchi Jun4,Nagai So5,Omori Kazuno1ORCID,Tsuchida Kazuhisa1ORCID,Miya Aika1ORCID,Shigesawa Ikumi15,Tsuchida Kenichi6,Yanagiya Shingo1,Kameda Hiraku1ORCID,Yokoyama Hiroki7ORCID,Taneda Shinji6,Kurihara Yoshio8,Aoki Shin9,Nishimoto Naoki10,Atsumi Tatsuya1,Miyoshi Hideaki111ORCID

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

2. Clinical Research and Medical Innovation Center Hokkaido University Hospital Sapporo Japan

3. Third Department of Internal Medicine Hokkaido PWFAC Obihiro‐Kosei General Hospital Obihiro Japan

4. Sapporo Diabetes and Thyroid Clinic Sapporo Japan

5. Division of Diabetes and Endocrinology Department of Medicine Sapporo Medical Center NTT East Corporation Sapporo Japan

6. Diabetes Center Manda Memorial Hospital Sapporo Japan

7. Department of Internal Medicine Jiyugaoka Medical Clinic Obihiro Japan

8. Kurihara Clinic Sapporo Japan

9. Aoki Clinic Sapporo Japan

10. Biostatistics Section Clinical Research and Medical Innovation Center Hokkaido University Hospital Sapporo Japan

11. Division of Diabetes and Obesity Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3